Inflammatix's Series A Round

Inflammatix raised a round of funding on May 25, 2017.

Inflammatix is a molecular diagnostics company that is developing rapid tests that read the immune system to resolve major clinical and public health challenges. The company's initial focus is on acut…

Articles about Inflammatix's Series A Round: